Highly polarized Th17 cells induce EAE via a T-bet independent mechanism

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 2824-2831

  Grifka Walk, Heather M ^a   Lalor, Stephen J ^a   Segal, Benjamin M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroimmunology; T bet; Th17 cells

Indexed keywords

CD4 ANTIGEN; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 23; INTERLEUKIN 6; RANTES; TRANSCRIPTION FACTOR T BET;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION;

EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; T-BET; TH17 CELLS;

ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHEMOKINE CCL5; CHEMOKINE CXCL2; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH17 CELLS;

EID: 84888027756     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343723     Document Type: Article

References (25)

1. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535-1541.
2. Axtell, R. C., de Jong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., De Sarno, P., Naves, R. et al., T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010. 16: 406-412.
3. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. G., Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 5-7.
4. Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B. and Waisman, A., IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009. 119: 61-69.
5. Kroenke, M. A., Chensue, S. W. and Segal, B. M., EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 2010. 40: 2340-2348.
6. Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H. et al., T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 2009. 206: 1549-1564.
7. Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M., Kung, A. L. et al., Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001. 292: 1907-1910.
8. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000. 100: 655-669.
9. Gocke, A. R., Cravens, P. D., Ben, L. H., Hussain, R. Z., Northrop, S. C., Racke, M. K. and Lovett-Racke, A. E., T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 2007. 178: 1341-1348.
10. Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O. and Weaver, C. T., Late developmental plasticity in the T helper 17 lineage. Immunity 2009. 30: 92-107.
11. Lexberg, M. H., Taubner, A., Förster, A., Albrecht, I., Richter, A., Kamradt, T., Radbruch, A. and Chang, H. D., Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 2008. 38: 2654-2664.
12. Mukasa, R., Balasubramani, A., Lee, Y. K., Whitley, S. K., Weaver, B. T., Shibata, Y., Crawford, G. E. et al., Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010. 32: 616-627.
13. Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H. et al., Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 2011. 12: 255-263.
14. Kurschus, F. C., Croxford, A. L., Heinen, A. P., Wörtge, S., Ielo, D. and Waisman, A., Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010. 40: 3336-3346.
15. Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H. and Kuchroo, V. K., Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 2004. 200: 79-87.
16. Lovett-Racke, A. E., Rocchini, A. E., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D. and Racke, M. K., Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 2004. 21: 719-731.
17. Frisullo, G., Angelucci, F., Caggiula, M., Nociti, V., Iorio, R., Patanella, A. K., Sancricca, C. et al., pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 2006. 84: 1027-1036.
18. Nath, N., Prasad, R., Giri, S., Singh, A. K. and Singh, I., T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology 2006. 118: 384-391.
19. Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M. et al., Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011. 35: 972-985.
20. Duhen, R., Glatigny, S., Arbelaez, C. A., Blair, T. C., Oukka, M. and Bettelli, E., Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet. J. Immunol. 2013. 190: 4478-4482.
21. King, I. L., Dickendesher, T. L. and Segal, B. M., Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009. 113: 3190-3197.
22. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G. X. et al., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011. 12: 568-575.
23. Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. and Becher, B., RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
24. Carlson, T., Kroenke, M., Rao, P., Lane, T. E. and Segal, B., The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 2008. 205: 811-823.
25. Lord, G. M., Rao, R. M., Choe, H., Sullivan, B. M., Lichtman, A. H., Luscinskas, F. W. and Glimcher, L. H., T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005. 106: 3432-3439.